Oramed Pharmaceuticals Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ORMP on Nasdaq
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 10/4/2024

Oramed Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nadav Kidron President and CEO, Director $6.22M Feb 11, 2025
Benjamin Shapiro Director $4.46M Jun 5, 2025
Miriam Kidron Chief Scientific Officer, Director $2.64M Feb 11, 2025
Joshua Hexter Coo & Cbo $1.84M Feb 11, 2025
Avraham Gabay Chief Financial Officer $959K Feb 11, 2025
David Silberman Chief Financial Officer $810K Jan 4, 2024
Yadin Rozov Director $343K Jan 4, 2024
Netanel Derovan Chief Legal Officer $330K May 26, 2023
Leonard Sank Director $301K Jun 5, 2025
Arie Mayer Director $298K Jun 5, 2025
Michael Rabinowitz Chief Commercial Officer $279K Jan 3, 2023
Michael Rabinowitz Chief Commercial Officer $242K Jan 3, 2022
Daniel Aghion Director $173K Jun 5, 2025
Yehuda Reznick Director $154K Jun 5, 2025
Kevin Rakin Director $103K Mar 21, 2022
Aviad Friedman Director Jan 3, 2022

Recent Insider Transactions by Companies or Individuals for Oramed Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.